ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0148

Air Pollution as a Trigger for Flares in Chronic Inflammatory Rheumatic Diseases: a Prospective Single-Center Study in the South of France

Coralie Cruzel1, antonio Iannelli2, Alexandre Armengaud3, Sonia Oppo3, Marie Charlotte Trojani4, Stephanie Ferrero4, Veronique Breuil4, Eric Fontas5, Christian Roux4 and Clément Viala4, 12. Department of Clinical Research, Cimiez Hospital, CHU Nice, Université Côte d'Azur, Nice, France, France, France, 23. Centre Hospitalier Universitaire de Nice-Digestive Surgery and Liver Transplantation Unit, Archet 2 Hospital, 06202 Nice, France., NIce, France, 31. University Cote d’Azur, Rheumatology department, CHU Nice, France, Marseille, France, 41. University Cote d’Azur, Rheumatology department, CHU Nice, France, NIce, France, 52. Department of Clinical Research, Cimiez Hospital, CHU Nice, Université Côte d'Azur, Nice, France, NIce, France

Meeting: ACR Convergence 2025

Keywords: Falls, rheumatoid arthritis, risk factors, spondyloarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 26, 2025

Title: (0145–0174) Epidemiology & Public Health Poster I

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Rheumatoid arthritis (RA) and spondyloarthritis (SpA), are chronic inflammatory rheumatic diseases. Despite significant advancements in their management through novel therapies, some patients continue to experience flares or therapeutic resistance. Environmental factors, particularly smoking and air pollution, are known contributors to disease activity and progression. However, the role of air pollutants in exacerbating these diseases remains debated, especially in SpA.

Methods: This prospective study included 94 patients with stable RA (DAS28 < 3.2) or SpA (BASDAI < 4) recruited between January and May 2023. All patients were on stable biological therapies. Air pollutant levels (PM2.5, PM10, NO2, and O3) were obtained from AtmoSud, a regional air quality monitoring body. Exposure was calculated based on the patient’s residential location over a 6-month period, with a focus on the 2 months preceding the first flare for patients experiencing disease exacerbations. Statistical analyses, including logistic regression and ROC curve analysis, were used to explore the relationship between pollutant levels and disease flares.

Results: : Sixty-one patients (65%) experienced at least one flare during the study period. Patients with flares had significantly higher exposure to PM10 (29 µg/m3 vs. 18.4 µg/m3, p=0.0003) and PM2.5 (11.7 µg/m3 vs. 8.5 µg/m3, p=0.0004). Conversely, lower exposure to ozone (O3) was associated with flares (71.9 µg/m3 vs. 104.6 µg/m3, p=0.0004). No significant differences were found for NO2 exposure. The multivariate analysis confirmed these associations, and ROC curves identified flare thresholds of 20.6 µg/m3 for PM10 and 9.5 µg/m3 for PM2.5.

Conclusion: Our findings highlight the role of air pollution, particularly particulate matter (PM2.5 and PM10), in triggering disease flares in patients with RA and SpA. These results support the need for stricter air quality standards to mitigate the impact of environmental factors on inflammatory rheumatic diseases.


Disclosures: C. Cruzel: None; a. Iannelli: None; A. Armengaud: None; S. Oppo: None; M. Trojani: None; S. Ferrero: None; V. Breuil: None; E. Fontas: None; C. Roux: None; C. Viala: None.

To cite this abstract in AMA style:

Cruzel C, Iannelli a, Armengaud A, Oppo S, Trojani M, Ferrero S, Breuil V, Fontas E, Roux C, Viala C. Air Pollution as a Trigger for Flares in Chronic Inflammatory Rheumatic Diseases: a Prospective Single-Center Study in the South of France [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/air-pollution-as-a-trigger-for-flares-in-chronic-inflammatory-rheumatic-diseases-a-prospective-single-center-study-in-the-south-of-france/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/air-pollution-as-a-trigger-for-flares-in-chronic-inflammatory-rheumatic-diseases-a-prospective-single-center-study-in-the-south-of-france/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology